Skip to search formSkip to main contentSkip to account menu

TLK-199

Known as: TER199, TLK 199, TLK199 
A liposomal small-molecule glutathione analog inhibitor of glutathione S-transferase (GST) P1-1 with hematopoiesis-stimulating activity. After… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Abstract 2778 Introduction: Lenalidomide is approved for the treatment of del(5q) MDS in US and Japan. In Low to Intermediate-1… 
2011
2011
Abstract 2779 Interpretation of gene expression studies in MDS have been especially challenging due to the heterogeneity of the… 
2010
2010
Treatment options for patients with lower risk non-del(5q) myelodysplastic syndromes (MDS) who fail erythroid stimulating agents… 
2008
2008
2270 TLK199 (ezatiostat hydrochloride) is a novel glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST… 
2007
2007
Introduction: Glutathione S-transferase (GST) P1-1 binds to and inhibits Jun kinase (JNK), a key regulator of cellular… 
2006
2006
TLK199 is a novel glutathione analog inhibitor of the enzyme GST P1-1. GST P1-1 has been shown to be a negative regulator of c… 
2004
2004
TelintraTM (TLK199) is a Novel Glutathione Inhibitor of GST P1-1. Telik scientists and academic collaborators reported… 
1997
1997
We previously raised a murine monoclonal antibody (mAb), OG-1, against human granulosa cells (GC) and reported that human GC… 
1963
1963
  • H. Zycha
  • 1963
  • Corpus ID: 13191116
\ u l 27. X<, \<. l l l l> , . l I l l l ,~ I>,'vin.L, i'l<+l,':;,<,Y I ) r \ \ ' ~ i u , l ! ; , l \ , . l l , I i i i i l l l i…